Neurologic Functional Capacity improvement – the ability to perform daily activities – has been noted in IRBs (safety testing), studies and Clinical Trials as well as patient case histories globally.
Stem Cell Therapies have shown to be highly successful in the treatment of conditions that involve the musculoskeletal system.
Stem Cell Therapy can treat conditions involving bone fractures, cartilage and joint function, joint injuries and degeneration.
Stroke occurs with the disruption of the blood supply to the brain, which causes lack of oxygen in the brain, and results in brain tissue destruction. Damage depends upon what part of the brain is affected as well as the severity of tissue loss. With a stroke, immediate treatment is required, but long-term management of inflammation and neovascularization of damaged tissue is essential. The anti-inflammatory and potential regenerative properties of stem cell therapy may offer a degree of recovery from the damage due to stroke.
Parkinson’s Disease (PD) is a chronic and progressive degenerative disorder of the nervous system caused by the destruction of the a specific neurotransmitter generating cell in the brain. Current research includes stem cell transplants in the hope that mesenchymal stem cells will mitigate the degenerative effects of the progressive PD.
ALS also known as Lou Gehrig’s disease is a progressive, debilitating neurologic disease that destroys the motor neurons in the brain and spinal cord. ALS is associated with rapidly progressive weakness, muscle wasting, spasticity, and difficulty breathing, swallowing and speaking. Many investigators are looking at using the regenerative properties of cell therapy to possibly mitigate the impact of ALS on the nervous system.
Multiple Sclerosis is a progressive, degenerative neurological disease that is caused by the destruction of the myelin sheaths (fatty protective insulation) around nerve fiber of the brain and spinal cord. Loss of myelin impairs these tissues to conduct signals and causes scarring resulting in a broad range of symptoms. This myelin damage appears to be related primarily to an auto-immune dysfunction and other factors. Investigators are looking at stem cell therapy to mitigate the impact of Multiple Sclerosis on the nervous system.
Alzheimer’s disease is a progressive, degenerative disease that gradually destroys memory and cognitive skills due to the accumulation of abnormal proteins that cause damage & dysfunction to the brain. As neurons (brain cells) lose function and ultimately die, damage becomes widespread and the brain actually shrinks. Stem cells may offer the possibility of re-growing healthy brain tissue. Trials investigating the ability of stem cells to rebuild lost nerve tissue and repair the damage caused by the progression of Alzheimer’s are currently underway.
Dementia includes a group of mental dysfunctional symptoms due to deficits in thinking, memory, and social abilities. People with dementia may experience memory loss, difficulty communicating, trouble organizing and planning, problems with coordination, disorientation and other aberrations.
Traumatic brain injury occurs when brain dysfunction ensues from external trauma causing dysfunction of brain cells. Mesenchymal stem cell therapy has been shown to improve functional recovery after traumatic brain injury.
PN peripheral neuropathy is a degenerative disorder of the nerves of the hands, legs and feet. It has many causes including Diabetes (often with auto-immune component), traumatic injuries, metabolic & and exposure to toxins. PN Peripheral neuropathy often causes symptoms of numbness and exquisite pain described as burning or tingling. It difficult to manage symptoms with medication. There is hope that mesenchymal stem cells will relieve some of the degenerative effects & pain of neuropathy.
Muscular dystrophy (MD) is a disease characterized by progressive skeletal muscle weakness from defects in muscle proteins resulting in the death of muscle cells and tissue. MD has a strong genetic component. Treatment options are limited at this time. There has been a much interest in using stem cells to regenerate muscle tissue and there has been success in using human stem cells for MD in mice. There is hope that stem cells and genetic engineering may eventually be effective in regenerating muscle damaged by MD.
Find the answers here to most frequently asked questions about Stem Cell Therapy
There are two main types of stem cells; adult stem cells and embryonic stem cells.
Adult Stem Cells or Mesenchymal Stem Cells (MSCs) are tissue specific. They typically can only generate different cell types for the specific tissue or organ in which they live. These cells are found in many organs and tissues, including brain, bone marrow, blood vessels, skeletal muscle, skin, teeth, heart, gut, liver and the reproductive organs.
Embryonic Stem Cells are derived from blastocysts created by in vitro fertilization (IVF) for assisted reproduction that were no longer needed. Because these kind of stem cells are undifferentiated and unspecialized, they can give rise to every type of cell in the body. It is not legal in this country to use this type of cell on humans as there is a great health risk associated with the use of this type of cell including Cancer.
Yes, Stem cell Therapy is less expensive than surgery.
Stem Cell Therapy is an outpatient procedure with minimal complications. A less aggressive alternative to surgery with no scarring OR NEGATIVE SIDE EFFECTS.
Yes, PRP and Stem Cell grafts are taken from your own body or placental allograft.
Recovery time is shorter compared to surgery. Usually pain diminishes in about seven to ten days. Motion increases recovery and is encouraged.
The procedure is completed in the office, usually between 1-2 hours.
Certain conditions that do not respond to traditional medical treatment can often respond to “Regenerative Therapies”